` OSX (Osteopore Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

OSX
vs
S
S&P/ASX 300

Over the past 12 months, OSX has underperformed S&P/ASX 300, delivering a return of -81% compared to the S&P/ASX 300's +6% growth.

Stocks Performance
OSX vs S&P/ASX 300

Loading
OSX
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
OSX vs S&P/ASX 300

Loading
OSX
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
OSX vs S&P/ASX 300

Loading
OSX
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Osteopore Ltd vs Peers

S&P/ASX 300
OSX
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Osteopore Ltd
Glance View

Market Cap
1.8m AUD
Industry
Health Care

Osteopore Ltd. develops and markets bioresorbable polymer implants for neurosurgical, orthopaedic and maxillofacial surgeries. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-09-23. The firm is engaged in commercializing a range of products to facilitate bone healing across multiple therapeutic areas. The company fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material using its platform technology. Its 3D print scaffold design is based on the principle of tissue engineering and regenerative medicine. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. Its craniofacial products are used as bone void fillers for regeneration of natural bone. The company also develops and manufactures implants that focuses on unmet clinical needs which improve patient outcomes. Its science of tissue engineering and regenerative medicine provides various surgical solutions for medical surgeons. Its products are used by surgeons across Asia, Europe, Australia, and the Americas.

OSX Intrinsic Value
0.057 AUD
Undervaluation 88%
Intrinsic Value
Price
Back to Top